EUVIMEDEUVIMED entdecken
Crossref

Authors’ Response: Therapeutic Drug Monitoring of Linezolid and Prevention of Optic Neurotoxicity in Drug-Resistant Tuberculosis

Sanjay Singhal, Kunal Deokar

Tuberculosis and Respiratory Diseases · 09.11.2026

DOI: 10.4046/trd.2026.0189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tuberculosis and Respiratory Diseases, online erschienen am 09.11.2026. Verfasst von Sanjay Singhal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, India. drsanjaysinghal79@yahoo.co.in.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Emergency Medicine, Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, India. drsanjaysinghal79@yahoo.co.in.
  • Department of Pulmonary Medicine, All India Institute of Medical Sciences-Rajkot, India.

Zitieren

APA

Singhal, S., & Deokar, K. (2026). Authors’ Response: Therapeutic Drug Monitoring of Linezolid and Prevention of Optic Neurotoxicity in Drug-Resistant Tuberculosis. Tuberculosis and Respiratory Diseases. https://doi.org/10.4046/trd.2026.0189

Vancouver

Singhal S, Deokar K. Authors’ Response: Therapeutic Drug Monitoring of Linezolid and Prevention of Optic Neurotoxicity in Drug-Resistant Tuberculosis. Tuberculosis and Respiratory Diseases. 2026. doi:10.4046/trd.2026.0189

BibTeX
@article{Singhal2026,
  author = {Singhal, Sanjay and Deokar, Kunal},
  title = {Authors’ Response: Therapeutic Drug Monitoring of Linezolid and Prevention of Optic Neurotoxicity in Drug-Resistant Tuberculosis},
  journal = {Tuberculosis and Respiratory Diseases},
  year = {2026},
  doi = {10.4046/trd.2026.0189}
}
Kostenlos starten →